Construction method and application of acute pancreatitis animal model
By designing a construction method for an animal model of acute pancreatitis, including selecting appropriate animals and controlling experimental procedures, the problems of complex operations and low success rates in the prior art are solved, and a highly reproducible model construction and research reference are achieved. value.
Patent Information
- Application Number
- CN202410891818.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-04
- Publication Date
- 2024-11-12
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing methods for building animal models of acute pancreatitis are complex in operation, prone to bleeding, waste of drugs, low success rate, and are not suitable for long-term observation, which affects the research results.
By designing a construction method for an animal model of acute pancreatitis, including determining research questions, selecting appropriate animals, obtaining ethical approval, preparing experimental equipment and materials, mixing chlorpromazine and ethanol to prepare mixed liquids, gavage or injecting into the animal's stomach , observe and perform pathological examinations, control dose and operating procedures to simulate different types of acute pancreatitis.
A highly reproducible acute pancreatitis model is realized, which simplifies operation, reduces costs, is suitable for beginners, and provides an important reference for studying pathogenesis and treatment methods.
Smart Images

Figure CN118924470A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of animal models, in particular to a method for constructing an acute pancreatitis animal model and application thereof. Background Art
[0002] Acute pancreatitis is one of the most common acute abdominal diseases in clinical practice. With the continuous improvement of people's living standards, its incidence rate has also shown a gradual upward trend, especially severe acute pancreatitis, with a mortality rate of up to 15% to 20%. Due to the excessive activation of pancreatic enzymes, the pancreas and its adjacent tissues will be inflamed, edematous, hemorrhaged, necrotic and other changes, causing macrophages and neutrophils to produce a large number of inflammatory mediators and cytotoxins, further causing endothelial cell damage, platelet adhesion and aggregation in the local area, thus causing microcirculation disorders, breaking the balance between inflammatory factors and anti-inflammatory factors, causing systemic inflammatory response syndrome, and ultimately leading to multiple organ failure;
[0003] In recent years, the study of acute pancreatitis has attracted the attention of many scholars, and different modeling methods directly affect the research results. The current common acute pancreaticobiliary duct injection method has a complicated operation process, damages blood vessels and is prone to bleeding, puncture "false channels" overflow leads to drug waste and reduces the success rate of the model, the survival time of modeled rats is short, the mortality rate is high, and it is not conducive to long-term observation. It is necessary to design a method for constructing and using an acute pancreatitis animal model. Summary of the invention
[0004] The purpose of the present invention is to provide a method for constructing an acute pancreatitis animal model and its use, so as to solve the problems raised in the above background technology.
[0005] To achieve the above object, the present invention provides the following technical solutions:
[0006] A method for constructing an acute pancreatitis animal model comprises the following steps:
[0007] Step S1, preparation work, the following preparation work needs to be performed before constructing the acute pancreatitis animal model, and the steps include:
[0008] Step S1-1, determine the research question. Before building the animal model, it is necessary to first determine the research question and purpose, and clarify the required animal species, quantity and treatment method;
[0009] Step S1-2, select appropriate animals, according to the research questions and purposes, select appropriate animal species, such as rats, mice, rabbits, etc., while considering factors such as the animal's physiological characteristics, metabolic capacity, susceptibility, etc.;
[0010] Step S1-3, designing an experimental plan, which includes selecting appropriate experimental methods, treatment methods, dosages and time, and controlling the differences between the control group and the experimental group;
[0011] Step S1-4, obtaining ethical approval: Before conducting animal experiments, ethical approval is required to ensure that the experiments comply with relevant ethical standards and regulations, while taking into account the welfare and rights of animals;
[0012] Step S2, feeding and numbering. In addition to the preparatory work before construction, the animals used for the animal model need to be centrally processed. The processing methods include feeding animals, marking and numbering animals. Feeding animals means providing a suitable feeding environment, feed and water source to ensure the health of the animals before the experiment. Marking and numbering animals means marking and numbering each animal for distinction and tracking;
[0013] Step S3, preparation before the experiment. After the preparation before the experiment and the animal treatment are completed, it is necessary to prepare the experimental equipment and materials;
[0014] The experimental equipment includes: gavage needles, syringes, surgical knives, medicines, etc.
[0015] The experimental materials include: rats or mice, chlorpromazine, ethanol, gavage needles and syringes, etc.;
[0016] Step S4, animal experiment, during the experiment, chlorpromazine and ethanol are mixed in a ratio of 1:1 to prepare a mixed liquid, rats or mice are randomly divided into two groups, one group is used as a control group, and the other group is injected with the mixed liquid to induce pancreatitis, for the injection group, the mixed liquid is injected into the stomach of the rats or mice using a gavage needle or syringe, the dosage can be determined according to the weight of the animal, generally 50 ml of the mixed liquid per kilogram of body weight, the injection group is given enough water and food, and its behavior and appetite changes are observed, 24 hours after the injection, the pancreas is removed for pathological examination to observe whether pathological manifestations of pancreatitis, such as cell infiltration, necrosis, etc., appear, and for the control group, the pancreatic pathological examination is also performed to determine whether spontaneous pancreatitis exists;
[0017] Step S5, recording and observation, after the animal experiment is completed, it needs to be processed according to the following steps;
[0018] Step S5-1, record experimental data: During the experiment, record the experimental data and results, including the weight, behavior, symptoms, pathological manifestations, etc. of the animals, for subsequent analysis and summary, and observe and record the symptoms of the animals;
[0019] Step S5-2, after the animal model is constructed, it is necessary to observe and record the symptoms and behavioral changes of the animal, such as body weight, appetite, activity level, etc.;
[0020] Step S5-3, pathological examination: For some disease models, pathological examination is required to observe the pathological changes of tissues and organs, such as cell infiltration, necrosis, etc.;
[0021] Step S6, analysis and conclusion: after the animal experiment is completed, statistical analysis and interpretation are performed based on the experimental data and results to clarify the conclusions and inferences of the experiment. Based on the experimental results, scientific papers are written and published to share the experimental results and experience and promote research and development in this field;
[0022] Furthermore, in step S1, the experimental scheme is designed to specifically include surgical operations, drug treatment, genetic modification, etc., and the appropriate experimental dose and time are determined according to the weight, metabolic capacity and characteristics of the animal to avoid excessive or insufficient effects;
[0023] Furthermore, in step S3, the animal species selected for acute pancreatitis should be changed accordingly according to the different causes of the disease. Male dogs should be used for the acute pancreatitis model induced by pancreatic duct ligation, and rats should be used for the acute hemorrhagic pancreatitis model induced by sodium cholate.
[0024] Furthermore, in step S3 and step S4, when conducting animal experiments, relevant ethics and regulations need to be followed to ensure the welfare and rights of animals. At the same time, the laboratory needs to be kept clean and safe during the experiment to avoid cross infection and accidents.
[0025] Furthermore, in step S4 and step S6, for the acute pancreatitis animal model experiment, it is also necessary to collect and separate samples, such as blood, urine, tissue, etc., and then perform analysis and detection, such as biochemical indicators, gene expression, etc.;
[0026] Use of an acute pancreatitis animal model:
[0027] The acute pancreatitis animal model is used to study the pathogenesis, pathophysiological changes, inflammatory response and pharmacodynamics of new drugs of acute pancreatitis. Acute pancreatitis is a serious disease, and the construction of the acute pancreatitis animal model is of great significance for studying its pathogenesis and treatment methods.
[0028] Compared with the prior art, the present invention has the following beneficial effects:
[0029] 1. The present invention can make the animal model produce highly reproducible acute pancreatitis by controlling the infusion dose and operation procedure, which has important reference value for studying the pathogenesis and treatment methods of pancreatitis, and different types of stimulating substances can be used according to research needs and purposes to simulate different types of acute pancreatitis;
[0030] 2. The present invention can finely control factors such as the infusion dose and the operating procedure, and can adjust and change the severity of pancreatitis, so as to better study its influencing factors and treatment effects. The establishment of the gavage-type acute pancreatitis animal model is relatively simple, does not require complex equipment and technology, and can be completed with only basic cytological laboratory facilities. It is easy to operate and suitable for beginners.
[0031] 3. Compared with other pancreatitis animal models, the oral gavage acute pancreatitis animal model of the present invention uses a smaller infusion dose, a shorter injection time, and requires fewer animals, so the cost is relatively low. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 The present invention is a schematic diagram of a construction method and use flow of an acute pancreatitis animal model. DETAILED DESCRIPTION
[0033] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0034] See also Figure 1 , the present invention provides a technical solution:
[0035] A method for constructing an acute pancreatitis animal model comprises the following steps:
[0036] Step S1, preparation work, the following preparation work needs to be performed before constructing the acute pancreatitis animal model, and the steps include:
[0037] Step S1-1, determine the research question. Before building the animal model, it is necessary to first determine the research question and purpose, and clarify the required animal species, quantity and treatment method;
[0038] Step S1-2, select appropriate animals, according to the research questions and purposes, select appropriate animal species, such as rats, mice, rabbits, etc., while considering factors such as the animal's physiological characteristics, metabolic capacity, susceptibility, etc.;
[0039] Step S1-3, designing an experimental plan, which includes selecting appropriate experimental methods, treatment methods, dosages and time, and controlling the differences between the control group and the experimental group;
[0040] Step S1-4, obtaining ethical approval: Before conducting animal experiments, ethical approval is required to ensure that the experiments comply with relevant ethical standards and regulations, while taking into account the welfare and rights of animals;
[0041] Step S2, feeding and numbering. In addition to the preparatory work before construction, the animals used for the animal model need to be centrally processed. The processing methods include feeding animals, marking and numbering animals. Feeding animals means providing a suitable feeding environment, feed and water source to ensure the health of the animals before the experiment. Marking and numbering animals means marking and numbering each animal for distinction and tracking;
[0042] Step S3, preparation before the experiment. After the preparation before the experiment and the animal treatment are completed, it is necessary to prepare the experimental equipment and materials;
[0043] The experimental equipment includes: gavage needles, syringes, surgical knives, medicines, etc.
[0044] The experimental materials include: rats or mice, chlorpromazine, ethanol, gavage needles and syringes, etc.;
[0045] Step S4, animal experiment, during the experiment, chlorpromazine and ethanol are mixed in a ratio of 1:1 to prepare a mixed liquid, rats or mice are randomly divided into two groups, one group is used as a control group, and the other group is injected with the mixed liquid to induce pancreatitis, for the injection group, the mixed liquid is injected into the stomach of the rats or mice using a gavage needle or syringe, the dosage can be determined according to the weight of the animal, generally 50 ml of the mixed liquid per kilogram of body weight, the injection group is given enough water and food, and its behavior and appetite changes are observed, 24 hours after the injection, the pancreas is removed for pathological examination to observe whether pathological manifestations of pancreatitis, such as cell infiltration, necrosis, etc., appear, and for the control group, the pancreatic pathological examination is also performed to determine whether spontaneous pancreatitis exists;
[0046] Step S5, recording and observation, after the animal experiment is completed, it needs to be processed according to the following steps;
[0047] Step S5-1, record experimental data: During the experiment, record the experimental data and results, including the weight, behavior, symptoms, pathological manifestations, etc. of the animals, for subsequent analysis and summary, and observe and record the symptoms of the animals;
[0048] Step S5-2, after the animal model is constructed, it is necessary to observe and record the symptoms and behavioral changes of the animal, such as body weight, appetite, activity level, etc.;
[0049] Step S5-3, pathological examination: For some disease models, pathological examination is required to observe the pathological changes of tissues and organs, such as cell infiltration, necrosis, etc.;
[0050] Step S6, analysis and conclusion: after the animal experiment is completed, statistical analysis and interpretation are performed based on the experimental data and results to clarify the conclusions and inferences of the experiment. Based on the experimental results, scientific papers are written and published to share the experimental results and experience and promote research and development in this field;
[0051] In the present invention, in step S1, the experimental scheme is specifically designed to include surgical operations, drug treatment, genetic modification, etc., and the appropriate experimental dose and time are determined according to the weight, metabolic capacity and characteristics of the animal to avoid excessive or insufficient effects;
[0052] In the present invention, in step S3, the animal species selected for acute pancreatitis needs to be changed accordingly according to the different causes of the disease. Male dogs should be used for the acute pancreatitis model induced by pancreatic duct ligation, and rats should be used for the acute hemorrhagic pancreatitis model induced by sodium cholate.
[0053] In the present invention, in step S4, when conducting animal experiments, it is necessary to comply with relevant ethics and regulations to ensure the welfare and rights of animals. At the same time, during the experiment, it is necessary to keep the laboratory clean and safe to avoid cross infection and accidents.
[0054] In the present invention, in step S6, for the acute pancreatitis animal model experiment, it is also necessary to collect and separate samples, such as blood, urine, tissue, etc., and then analyze and detect, such as biochemical indicators, gene expression, etc.;
[0055] Use of an acute pancreatitis animal model:
[0056] The acute pancreatitis animal model is used to study the pathogenesis, pathophysiological changes, inflammatory response and pharmacodynamics of new drugs of acute pancreatitis. Acute pancreatitis is a serious disease, and the construction of the acute pancreatitis animal model is of great significance for studying its pathogenesis and treatment methods.
[0057] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.
[0058] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A method for constructing an acute pancreatitis animal model, characterized in that: The following steps are involved: Step S1, preparation work, the following preparation work needs to be performed before constructing the acute pancreatitis animal model, and the steps include: Step S1-1, determine the research question. Before building the animal model, it is necessary to first determine the research question and purpose, and clarify the required animal species, quantity and treatment method; Step S1-2, select appropriate animals, such as rats, mice, rabbits, etc., according to the research questions and purposes, while considering factors such as the physiological characteristics, metabolic capacity, susceptibility, etc. of the animals; Step S1-3, designing an experimental plan, which includes selecting appropriate experimental methods, treatment methods, dosages and time, and controlling the differences between the control group and the experimental group; Step S1-4, obtaining ethical approval: Before conducting animal experiments, ethical approval is required to ensure that the experiments comply with relevant ethical standards and regulations, while taking into account the welfare and rights of animals; Step S2, feeding and numbering. In addition to the preparatory work before construction, the animals used for the animal model need to be centrally processed. The processing methods include feeding animals, marking and numbering animals. Feeding animals means providing a suitable feeding environment, feed and water source to ensure the health of the animals before the experiment. Marking and numbering animals means marking and numbering each animal for distinction and tracking; Step S3, preparation before the experiment. After the preparation before the experiment and the animal treatment are completed, it is necessary to prepare the experimental equipment and materials; The experimental equipment includes: gavage needles, syringes, surgical knives, medicines, etc. The experimental materials include: rats or mice, chlorpromazine, ethanol, gavage needles and syringes, etc.; Step S4, animal experiment, during the experiment, chlorpromazine and ethanol are mixed in a ratio of 1:1 to prepare a mixed liquid, rats or mice are randomly divided into two groups, one group is used as a control group, and the other group is injected with the mixed liquid to induce pancreatitis, for the injection group, the mixed liquid is injected into the stomach of the rats or mice using a gavage needle or syringe, the dosage can be determined according to the weight of the animal, generally 50 ml of the mixed liquid per kilogram of body weight, the injection group is given enough water and food, and its behavior and appetite changes are observed, 24 hours after the injection, the pancreas is removed for pathological examination to observe whether pathological manifestations of pancreatitis, such as cell infiltration, necrosis, etc., appear, and for the control group, the pancreatic pathological examination is also performed to determine whether spontaneous pancreatitis exists; Step S5, recording and observation, after the animal experiment is completed, it needs to be processed according to the following steps; Step S5-1, record experimental data: During the experiment, record the experimental data and results, including the weight, behavior, symptoms, pathological manifestations, etc. of the animals, for subsequent analysis and summary, and observe and record the symptoms of the animals; Step S5-2, after the animal model is constructed, it is necessary to observe and record the symptoms and behavioral changes of the animal, such as body weight, appetite, activity level, etc.; Step S5-3, pathological examination: For some disease models, pathological examination is required to observe the pathological changes of tissues and organs, such as cell infiltration, necrosis, etc.; Step S6, analysis and conclusion, after the animal experiment is completed, statistical analysis and interpretation are carried out based on the experimental data and results to clarify the conclusions and inferences of the experiment. Based on the experimental results, scientific papers are written and published to share the experimental results and experience and promote research and development in this field.
2. The method for constructing an acute pancreatitis animal model according to claim 1, characterized in that: In step S1, the experimental scheme is designed to specifically include surgical operations, drug treatment, genetic modification, etc. At the same time, the appropriate experimental dose and time are determined according to the weight, metabolic capacity and characteristics of the animal to avoid excessive or insufficient effects.
3. The method for constructing an acute pancreatitis animal model according to claim 1, characterized in that: In step S3, the animal species selected for acute pancreatitis needs to be changed accordingly according to the different causes of the disease. Male dogs should be used for the acute pancreatitis model induced by pancreatic duct ligation, and rats should be used for the acute hemorrhagic pancreatitis model induced by sodium cholate.
4. The method for constructing an acute pancreatitis animal model according to claim 1, characterized in that: In step S4, when conducting animal experiments, it is necessary to comply with relevant ethics and regulations to ensure the welfare and rights of animals. At the same time, during the experiment, it is necessary to keep the laboratory clean and safe to avoid cross infection and accidents.
5. The method for constructing an acute pancreatitis animal model according to claim 1, characterized in that: In step S6, for the acute pancreatitis animal model experiment, it is also necessary to collect and separate samples, such as blood, urine, tissue, etc., and then perform analysis and detection, such as biochemical indicators, gene expression, etc.
6. Use of an acute pancreatitis animal model according to claims 1-5, characterized in that: The acute pancreatitis animal model is used to study the pathogenesis, pathophysiological changes, inflammatory response and pharmacodynamics of new drugs of acute pancreatitis. Acute pancreatitis is a serious disease, and the construction of the acute pancreatitis animal model is of great significance for studying its pathogenesis and treatment methods.
